TY - JOUR
T1 - Individual supported work placements (ReISE) for improving sustained return to work in unemployed people with persistent pain
T2 - an internal pilot study of a cohort randomised controlled approach
AU - Amundsen, Pål André
AU - Underwood, Martin
AU - Burton, Kim
AU - Grotle, Margareth
AU - Engedahl, Martin Stav
AU - Malmberg-Helmonen, Ira
AU - Stähr Irgens, Pernille Marie
AU - Højen, Magnus
AU - Kisa, Adnan
AU - Hagen, Milada
AU - Holmgard, Thor Einar
AU - Martinsen, Amy
AU - Lothe, Jakob
AU - Spilde Monsen, Sølvi
AU - Froud, Rob
N1 - Funding Information:
RF and MU are directors and shareholders of Clinvivo Ltd, a University of Warwick spin-out company that provides data collection services to health services researchers. However, Clinvivo\u2019s services were not used in this study and will not be used in the main trial. MU is the chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research, and is a co-investigator on grants funded by the Australian NHMRC. He was an NIHR Senior Investigator until March 2021. RF and MU are part of an academic partnership with Serco Ltd, funded by the European Social Fund, related to return-to-work initiatives. MU is a co-investigator on two current and one completed NIHR-funded studies that have, or have had, additional support from Stryker Ltd. While the leaflets are available electronically free of charge in the UK, KB has received royalties from the publisher when printed English language copies have been sold in the UK. All other authors declare that they have no competing interests.
Funding Information:
The funding for this trial was provided by the Norwegian Research Council through its Collaborative Project to meet Societal and Industry-related Challenges scheme (grant number 326732/ABHO) (Additional file 3).
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8/13
Y1 - 2024/8/13
N2 - BACKGROUND: Persistent pain is a frequent cause of sick leave and work disability in Norway. A return-to-work intervention featuring supported work placements, developed in the UK, demonstrated feasibility, and a return-to-work rate of 20% within 6 months was observed in the sample. We sought to adapt the intervention for delivery in Norway and to confirm feasibility prior to a full-scale trial.METHODS: In this internal pilot, we used a pragmatic cohort randomised controlled approach with national recruitment in Norway. We recruited people who were unemployed (for at least 1 month), having persistent pain (for at least 3 months), aged between 18 and 64, and wanting to return to work. We initially recruited people to an observational cohort study of the impact of being unemployed with persistent pain. After baseline measurement, we randomly sub-sampled participants to whom we offered the intervention, which featured individual case management and support, work-familiarisation sessions, and the offer of a 6-week part-time unpaid work placement. We assessed recruitment rates (aiming to recruit 66, and sub-sample 17 within 6 months); optimal recruitment pathways; intervention acceptance rates; the feasibility of data collection; using video links for work-familiarisation sessions and remote case manager support.RESULTS: The pilot ran from June to November 2022. Of 168 people expressing interest, 94 consented. Recruitment posts on Facebook yielded the most 'expressions of interest' (66%, n = 111). After screening for eligibility, we included 55 participants. Of these, 19 were randomised to be offered the intervention. Of these, less than half (n = 8) consented to intervention participation. Remote case manager and work-familiarisation sessions appeared feasible. Following a delay in identifying placements, three participants received offers of work placements, with one starting and completing during the pilot period. Data collection methods were feasible, and no adverse events were reported.CONCLUSIONS: Recruitment and logistical processes, such as remote management by video link, are feasible. However, delivery of the intervention is challenging. In particular, sourcing placements and the time required for identifying appropriate placements was more challenging than anticipated. A full-scale trial is feasible but will require improvements to the placement identification processes.TRIAL REGISTRATION: ISRCTN85437524 (Referring to the ReISE trial, of which this internal pilot was a part), Registered 31 of May 2022 https://doi.org/10.1186/ISRCTN85437524 TRIAL FUNDING: Norwegian Research Council.
AB - BACKGROUND: Persistent pain is a frequent cause of sick leave and work disability in Norway. A return-to-work intervention featuring supported work placements, developed in the UK, demonstrated feasibility, and a return-to-work rate of 20% within 6 months was observed in the sample. We sought to adapt the intervention for delivery in Norway and to confirm feasibility prior to a full-scale trial.METHODS: In this internal pilot, we used a pragmatic cohort randomised controlled approach with national recruitment in Norway. We recruited people who were unemployed (for at least 1 month), having persistent pain (for at least 3 months), aged between 18 and 64, and wanting to return to work. We initially recruited people to an observational cohort study of the impact of being unemployed with persistent pain. After baseline measurement, we randomly sub-sampled participants to whom we offered the intervention, which featured individual case management and support, work-familiarisation sessions, and the offer of a 6-week part-time unpaid work placement. We assessed recruitment rates (aiming to recruit 66, and sub-sample 17 within 6 months); optimal recruitment pathways; intervention acceptance rates; the feasibility of data collection; using video links for work-familiarisation sessions and remote case manager support.RESULTS: The pilot ran from June to November 2022. Of 168 people expressing interest, 94 consented. Recruitment posts on Facebook yielded the most 'expressions of interest' (66%, n = 111). After screening for eligibility, we included 55 participants. Of these, 19 were randomised to be offered the intervention. Of these, less than half (n = 8) consented to intervention participation. Remote case manager and work-familiarisation sessions appeared feasible. Following a delay in identifying placements, three participants received offers of work placements, with one starting and completing during the pilot period. Data collection methods were feasible, and no adverse events were reported.CONCLUSIONS: Recruitment and logistical processes, such as remote management by video link, are feasible. However, delivery of the intervention is challenging. In particular, sourcing placements and the time required for identifying appropriate placements was more challenging than anticipated. A full-scale trial is feasible but will require improvements to the placement identification processes.TRIAL REGISTRATION: ISRCTN85437524 (Referring to the ReISE trial, of which this internal pilot was a part), Registered 31 of May 2022 https://doi.org/10.1186/ISRCTN85437524 TRIAL FUNDING: Norwegian Research Council.
KW - Persistent pain
KW - Chronic pain
KW - Health-related quality of life
KW - Return to work
KW - Supported employment
KW - Vocational rehabilitation
KW - Work disability
KW - Cohort randomised approach
KW - Case management
UR - http://www.scopus.com/inward/record.url?scp=85201290732&partnerID=8YFLogxK
U2 - 10.1186/s40814-024-01538-9
DO - 10.1186/s40814-024-01538-9
M3 - Article
C2 - 39138502
VL - 10
JO - Pilot and Feasibility Studies
JF - Pilot and Feasibility Studies
SN - 2055-5784
IS - 1
M1 - 110
ER -